This article provides a comprehensive overview of CRISPR base editing, a revolutionary gene-editing technology that enables precise nucleotide conversions without creating double-strand DNA breaks (DSBs).
This article provides a detailed, current overview of CRISPR base editing technologies for precise correction of point mutations.
This article provides a comprehensive analysis of CRISPR-Cas systems as the adaptive immune defense mechanism in prokaryotes, targeting researchers, scientists, and drug development professionals.
This article provides a comprehensive guide for researchers and drug development professionals on the critical role of CRISPR amplification methods in profiling rare off-target editing events.
This article provides a comprehensive technical review for researchers and drug development professionals on the novel CRISPR delivery platform combining lipid nanoparticles (LNPs) with spherical nucleic acids (SNAs).
This comprehensive guide addresses the persistent challenge of low Homology-Directed Repair (HDR) efficiency in CRISPR-Cas9 genome editing.
This article provides a comprehensive, step-by-step protocol for researchers struggling with low homology-directed repair (HDR) rates in hard-to-edit cell types, such as primary cells, neurons, and stem cells.
This article provides a detailed, evidence-based analysis of the efficiency, precision, and practical applications of CRISPR-Cas9, TALEN, and ZFN genome editing platforms.
This article provides a critical, evidence-based comparison of off-target effects across the three primary genome editing platforms: CRISPR-Cas9, TALENs, and ZFNs.
This article provides a comprehensive guide for researchers and drug development professionals on implementing CRISPR-Cas9 gene editing in primary human cells.